Post‐Translational Modifications in Pancreatic Cancer: Mechanisms to Clinical Applications
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70441 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Guoqing Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Lanzhou University, Gansu, Lanzhou, China. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Joint Research Fund General Projects of Gansu Province, Major Science and Technology Projects of Gansu Province.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, characterized by an extremely low 5‐year survival rate. Its aggressiveness is attributed to early metastasis, rapid progression, and resistance to conventional therapies. Post‐translational modifications (PTMs), which involve covalent modifications of amino acid residues, dynamically regulate protein activity, stability, and interactions. Increasing evidence has identified PTMs as key drivers in the pathogenesis of PDAC. PTMs encompass classical modifications such as phosphorylation, acetylation, glycosylation, ubiquitination, and methylation, as well as emerging modifications including SUMOylation, lysine crotonylation, and palmitoylation. This review first summarizes the mechanistic roles of both classical and novel PTMs in PDAC. It then explores the crosstalk among different types of PTMs and their integrated impact on PDAC progression. Finally, this review provides a theoretical basis for identifying early diagnostic biomarkers and potential targets for personalized therapy in PDAC. Overall, this work lays a conceptual foundation for future studies aimed at deciphering the complex PTM networks and their contributions to PDAC malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, Lanzhou University, Gansu, Lanzhou, China.
- Department of General Surgery, The Second Hospital of Lanzhou University, Gansu, Lanzhou, China.
- Key Laboratory of Environmental Oncology of Gansu Province, Lanzhou, China.
ORCID-Profile: Guoqing Zhang, Weixiong Zhu, Yongqing Zhao
Förderung
- National Natural Science Foundation of China
- Joint Research Fund General Projects of Gansu Province
- Major Science and Technology Projects of Gansu Province
Zitieren
APA
Zhang, G., Zhu, W., Zhao, Y., Cheng, Y., & Zhou, W. (2026). Post‐Translational Modifications in Pancreatic Cancer: Mechanisms to Clinical Applications. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70441
Vancouver
Zhang G, Zhu W, Zhao Y, Cheng Y, Zhou W. Post‐Translational Modifications in Pancreatic Cancer: Mechanisms to Clinical Applications. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70441
BibTeX
@article{Zhang2026,
author = {Zhang, Guoqing and Zhu, Weixiong and Zhao, Yongqing and Cheng, Yusheng and Zhou, Wence},
title = {Post‐Translational Modifications in Pancreatic Cancer: Mechanisms to Clinical Applications},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70441}
}
EUVIMED